LFMD News and Press, LifeMD Inc.

2024-07-16 07:05:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Healthcare portfolios include telehealth stocks, notably after the COVID-19 pandemic, which increased global telemedicine usage, demonstrating their importance for lockdowns and other social is...

2024-06-26 05:10:56 ET Summary Medifast is a leader in dietary weight management that fell off a cliff since 2022 due to inflationary pressures, the re-opening of restaurants, and the rise of GLP-1 drugs. The company's turnaround plan aims to combine OPTAVIA offerings with direct ...

NEW YORK, June 25, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD) today announced the launch of private health insurance acceptance for its virtual primary care services, including weight management for medically qualified patients. Initially available in select states, the company plan...

2024-06-11 14:59:23 ET Summary Identifying investment opportunities in the healthcare sector involves research on trends and next-gen tech. LifeMD offers telehealth services and weight management programs, positioned for growth in the underserved obesity market. Risks include ...

NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that management will be participating in the Truist Securities Healthcare Disruptors & Digital Health Summit taking place June 25-26, 2024 at the Lot...

2024-06-05 13:44:31 ET More on LifeMD LifeMD: Moving Towards Profitability LifeMD, Inc. (LFMD) Q1 2024 Earnings Call Transcript LifeMD, Inc. 2024 Q1 - Results - Earnings Call Presentation LifeMD Q1 2024 Earnings Preview LifeMD Non-GAAP EPS of $0.15 be...

2024-06-04 20:00:05 ET Steve Dechert from KeyBanc issued a price target of $12.00 for LFMD on 2024-06-04 18:08:00. The adjusted price target was set to $12.00. At the time of the announcement, LFMD was trading at $7.53. The overall price target consensus is at $14.00 wit...

2024-06-04 19:30:01 ET KeyBanc analyst issues OVERWEIGHT recommendation for LFMD on June 4, 2024 06:08PM ET. LFMD was trading at $7.53 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 3 - Buy recommendatio...

2024-05-30 17:29:56 ET The Russell 3000 index will have a new look on June 28, after the market closes, when 225 securities will be added and 144 securities will be deleted as part of the annual reconstitution. Following are some notable consumer staples companies which will be ...

2024-05-29 08:24:18 ET More on LifeMD LifeMD: Moving Towards Profitability LifeMD Non-GAAP EPS of $0.15 beats by $0.12, revenue of $44.86M beats by $4.37M Read the full article on Seeking Alpha For further details see: LifeMD set to join Russell 3000 Index